Design of a prospective patient‐level pooled analysis of two parallel trials of empagliflozin in patients with established heart failure

AIM: The EMPEROR‐Reduced trial demonstrated that empagliflozin reduced the combined risk of cardiovascular death or hospitalization for heart failure in patients with a reduced ejection fraction, and the EMPEROR‐Preserved trial is currently evaluating the effect of the drug on the same endpoint in p...

Deskribapen osoa

Gorde:
Xehetasun bibliografikoak
Argitaratua izan da:Eur J Heart Fail
Egile Nagusiak: Packer, Milton, Butler, Javed, Filippatos, Gerasimos, Zannad, Faiez, Ferreira, Joao Pedro, Zeller, Cordula, Brueckmann, Martina, Jamal, Waheed, Pocock, Stuart J., Anker, Stefan D.
Formatua: Artigo
Hizkuntza:Inglês
Argitaratua: John Wiley & Sons, Ltd. 2020
Gaiak:
Study Design
Sarrera elektronikoa:https://ncbi.nlm.nih.gov/pmc/articles/PMC7898542/
https://ncbi.nlm.nih.gov/pubmed/33251659
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1002/ejhf.2065
Etiketak: Etiketa erantsi
Etiketarik gabe, Izan zaitez lehena erregistro honi etiketa jartzen!

Antzeko izenburuak